Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease-Reference-Cited by-同舟云学术

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

Published:1999-10 Issue:4 Volume:117 Page:761-769
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Rutgeerts Paul,D'Haens Geert,Targan Stephan,Vasiliauskas Eric,Hanauer Stephen B.,Present Daniel H.,Mayer Lloyd,Van Hogezand Ruud A.,Braakman Tanja,DeWoody Kimberly L.,Schaible Thomas F.,Van Deventer Sander J.H.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference18 articles.

1. Management of Crohn's disease in adults;Hanauer;Am J Gastroenterol,1997

2. Tumour necrosis factor and Crohn's disease;van Deventer;Gut,1997

3. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review;Brynskov;Dig Dis,1994

4. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease;Reimund;J Clin Immunol,1996

5. Increased production of tumour necrosis factor-α, interleukin-β, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease;Reimund;Gut,1996

Cited by 953 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

2. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment;Journal of Crohn's and Colitis;2024-06-15

3. An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresis;Gastroenterología y Hepatología (English Edition);2024-04

4. Infliximab for maintenance of medically-induced remission in Crohn's disease;Cochrane Database of Systematic Reviews;2024-02-19

5. Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis;Digestive and Liver Disease;2024-01